Company
Zenflow
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
7
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$75.3M
3 Form D offerings, 2017 to 2024
Equity
$75.3M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $19.4M raised of $25.2M sought, first sale Nov 1, 2024, 36 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | Equity | $19.4M | $25.2M | 36 | Rule 506(b) | Form D ↗Nov 19, 2024 |
| Apr 9, 2021 | Equity | $24.4M | $24.4M | 43 | Rule 506(b) | Form D/A ↗May 20, 20211 amendment |
| Sep 12, 2017 | Equity | $31.5M | $32.2M | 86 | Rule 506(b) | Form D/A ↗Dec 27, 20171 amendment |
Company details
From the company's latest Form D.
- Legal name
- Zenflow, Inc.
- Headquarters
- South San Francisco, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1718715 ↗
Executives, directors and promoters
As listed on the latest Form D.
8 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
P250007 · Decided Dec 11, 2025 · 275 days after receipt
Device type: STENT, URETHRAL, PROSTATIC, PERMANENT OR SEMI-PERMANENT (MER) · GI, Urology & Nephrology
- Zenflow Spring Scope510(k)
K251140 · Decided Sep 23, 2025 · 162 days after receipt
Device type: Cystoscope And Accessories, Flexible/Rigid (FAJ) · GI, Urology & Nephrology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH.Pivotal-lookingNot yet recruiting
NCT07797348 · 110 participants (planned) · Start Sep 1, 2026 · Primary completion Sep 1, 2028
Device: Zenflow Arm: Zenflow Spring System implant procedure · For: Benign Prostatic Hyperplasia (BPH); Obstructive Lower Urinary Tract Symptoms (LUTS); Enlarged Prostate
NCT07538622 · 300 participants (planned) · Start Jul 29, 2026 · Primary completion Jul 2028
Device: Zenflow Spring System · For: BPH (Benign Prostatic Hyperplasia)
Sites: Phoenix, Arizona; La Mesa, California; Tampa, Florida · 8 sites in all
- Safety and Effectiveness Study of the Zenflow Spring SystemPivotal-lookingStatus unknown
NCT04987138 · 279 participants (planned) · Start Sep 30, 2021 · Primary completion Jun 30, 2024
Device: Zenflow Spring System; Sham Procedure · For: BPH (Benign Prostatic Hyperplasia); Lower Urinary Tract Symptoms (LUTS)
Sites: Los Angeles, California; Glenview, Illinois; Las Vegas, Nevada · 7 sites in all
4 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.